Replies to post #64068 on Blue Diamond Ventures Inc (BLDV)

[SRV1975]

Wow that is a MONSTER post Sterling! So much to DD to enjoy here!

[onco]

MUST have sticky

[brucebill]

Wow , what a great post,what a wonderful thing facts are.

[ctvette2003]

Now thats a DD post! Incredible work Sterve

[bikeguy]

Nice comprehensive post

[Rhinegold]

Impressive DD Stervc! Always appreciate your solid DD! This will see huge gains soon enough! Anywhere from pennies to .15+
$BLDV

[JPS02]

Great post stervc, thanks for responding. No one knows how to lay out the information like you do.

Thanks for the thoughtful insight.

Go BLDV!

[Rhinegold]

Definitely the total DD package right there! Needs to be Stickied BLDV

[JPS02]

Interview: CEO Joshua Alper of Blue Diamond Ventures, Inc. published on June 1, 2017

I think everyone should listen carefully to the CEO interview which I think is loaded with information items. Every time I listen to the interview, I see a different perspective/insight of what Josh is trying to explain.

Notice at 5:50 in the interview how Josh refers to grow operations being set up in Florida and how they are high tech. The CEO explains that in the MMJ industry they are more concerned with the exact complement of cannabinoids in the plant. Josh indicates it is more of a recipe relying on genetics and monitoring of controllable factors within controlled spaces.

BLDV's environmental control knowledge through their work with Zeno Controls and Verve Living Systems gave them the position to understand the total environment of the space. Josh indicates that in the MMJ industry, it is important to bring technology to different areas. Connect the dots!

Go BLDV!

[Wesley1961]

Sterling, thank you for your outstanding job what you do here. You are so precise, knowledgeable and you can prove everything what you say here, nobody can surprise you because you have your answer ready. Thank you for all you do to put the BLDV in the honest and bright light.

I really appreciate your job.

[JPS02]

Blue Diamond Consulting LLC (BDC)

100% wholly owned subsidiary

"Everything we do at BLDV starts with consulting," says Jonathan Alper, Manager of BDC and the Principle of Alper & Associates Consulting. "Land Development for Religious Organizations, including the development of the first residential projects built on leased land in Illinois, is still 50% of our business."

BDC has just secured a new contract to do the Master Planning and Project/Construction Management for 100 Acres of land owned by the Victory Christian Center in Pendleton NY, right outside of Buffalo. "We are seeing the results of partnering with BLDV, with the acquisition of this new client and contract," says Jonathan Alper a licensed Landscape Architect and a member of Lambda Alpha.

In addition to the Planning and Construction projects, Blue Diamond Consulting is responsible for the business development activities of all other BLDV business units and has several private clients in the cannabis space.

Source: https://www.otcmarkets.com/stock/BLDV/news/Blue-Diamond-Ventures-Inc--Outlines-Operational-Strategies-for-2017?id=157095&b=y

[JPS02]

Statement from Health Canada on Improving the Licensing of Production of Cannabis for Medical Purposes

Statements

From Health Canada

May 26, 2017 - Ottawa, ON - Health Canada

OTTAWA – Health Canada is introducing several improvements to its medical cannabis program that aim to streamline the application process for issuing production licenses and enable increased production under the Access to Cannabis for Medical Purposes Regulations (ACMPR).

Health Canada has drawn on nearly four years of experience to identify measures that can be put in place to streamline licensing and enable increased production of cannabis. These measures will also help ensure that Health Canada’s approach to licensing and oversight continues to be aligned with the regulations, the existing evidence of risks to public health and safety, and its approach to other regulated sectors.

Effective immediately, Health Canada is implementing the following measures:

• Increasing the Department’s capacity to review and process applications.

• Undertaking some stages of the review of the application concurrently.

• Permitting licensed producers to manage production on the basis of their vault capacity.

• Authorizing longer validity periods for licences and security clearances in accordance with the regulations.

• Streamlining the review and approval of applications to modify or expand an existing production facility for licensed producers with a record of good compliance with the ACMPR.

Health Canada will continue to inspect all facilities before cultivation begins and before a licence to sell products to the public is issued. Henceforth, Health Canada will schedule this first inspection after it has determined an application meets the regulatory requirements and it has issued the licence to cultivate and once the producer is ready to initiate production in its facility. This approach will help provide successful applicants with a decision on their application as soon as possible while ensuring that all facilities are inspected as cultivation begins.

Licensed producers and applicants must continue to meet all of the requirements under the Access to Cannabis for Medical Purposes Regulations (ACMPR). The ACMPR represents among the most robust frameworks in the world for ensuring effective control and regulation of cannabis for medical purposes. The ACMPR includes security and inventory control measures that help prevent diversion, as well as requirements for Good Production Practices that help provide individuals with access to quality-controlled cannabis for medical purposes. Since licensed production began in June 2013, licensed producers have established a solid record of compliance with the regulatory requirements and Health Canada will continue to ensure compliance through regular inspection.

In addition to the measures announced today, Health Canada has already dedicated additional resources to accelerate the processing of applications from individuals who are authorized to produce a limited amount of cannabis for their own medical purposes.

Health Canada will continue to work closely with patients, patient advocates and licensed producers to identify and act on opportunities to improve access to cannabis and service to Canadians.

Associated Links
Backgrounder - Improving the Licensing of Production of Cannabis for Medical Purposes

Contacts
Media Relations
Health Canada
613-957-2983

Public Inquiries
[phone]
1-866 225-0709

Source: https://www.canada.ca/en/health-canada/news/2017/05/statement_from_healthcanadaonimprovingthelicensingofproductionof.html